Effect of body size on the oral pharmacokinetics of oxytetracycline in rainbow trout (Oncorhynchus mykiss)

PeerJ. 2024 Sep 11:12:e17973. doi: 10.7717/peerj.17973. eCollection 2024.

Abstract

Objective: The aim of this study was to determine the plasma pharmacokinetics of oxytetracycline (OTC) in rainbow trout (Oncorhynchus mykiss) of different body sizes.

Methods: The research was carried out on three groups as small (30-50 g), medium (90-110 g) and large (185-215 g) body sizes at 8 ± 0.5 °C. OTC was administered orally at a dose of 60 mg/kg to all groups. Blood samples were taken at 19 different sampling times until the 384 h after oxytetracycline administration. The plasma concentrations of OTC were measured using high pressure liquid chromatography-ultraviolet and pharmacokinetic parameters were evaluated using non-compartmental analysis.

Results: OTC was detected in small-body sized fish until the 336 h and in medium and large-body sized fish until the 384 h. The elimination half-life of OTC was 85.46, 87.24 and 86.98 h in the small, medium and large body size groups, respectively. The peak plasma concentration increased from 0.66 to 1.11 µg/mL, and the area under the plasma concentration-versus time curve from zero (0) h to infinity (∞) increased from 87.86 to 151.52 h*µg/mL, in tandem with the increase in fish body size. As fish body size increased, volume of distribution and total body clearance decreased.

Conclusion: These results show that the pharmacokinetics of OTC vary depending on fish size. Therefore, there is a need to reveal the pharmacodynamic activity of OTC in rainbow trout of different body sizes.

Keywords: Body size; HPLC; Oxytetracycline; Pharmacokinetics; Rainbow trout.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / blood
  • Anti-Bacterial Agents* / pharmacokinetics
  • Body Size*
  • Chromatography, High Pressure Liquid
  • Half-Life
  • Oncorhynchus mykiss* / metabolism
  • Oxytetracycline* / administration & dosage
  • Oxytetracycline* / blood
  • Oxytetracycline* / pharmacokinetics

Substances

  • Oxytetracycline
  • Anti-Bacterial Agents

Grants and funding

This study was supported by The Coordination of Scientific Research Projects, University of Hatay Mustafa Kemal, Türkiye (Project No. 22.GAP.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.